Erratum: MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity

Affiliations

• ¹ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
• ² Department of Radiation and Medical Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming, China.
• ³ Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
• ⁴ Department of Pathology, China Three Gorges University Medical College, Yichang, China.
• ⁵ Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
• ⁶ Central Laboratory of Xinhua Hospital of Dalian University, Department of Medical Oncology, Xinhua Hospital of Dalian University, Dalian, China.
• ⁷ Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
• ⁸ Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.